These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 8371947

  • 1. [Determination of potential doubling time using in vitro continuous labeling method with bromodeoxyuridine: estimation in head and neck squamous cell carcinoma].
    Mariya Y, Aoki M, Tarusawa N, Takekawa S, Kaimori M, Abe Y.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug 25; 53(8):976-8. PubMed ID: 8371947
    [Abstract] [Full Text] [Related]

  • 2. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].
    Corvò R, Giaretti W, Sanguineti G, Geido E, Bacigalupo A, Franzone P, Mereu P, Garaventa G, Barbieri M, Vitale V.
    Radiol Med; 1993 Aug 25; 86(1-2):135-42. PubMed ID: 8346344
    [Abstract] [Full Text] [Related]

  • 3. [The in vivo use of bromodeoxyuridine for the study of cell kinetics in squamous tumors of the neck and head. Implications for the radiotherapist].
    Corvò R, Giaretti W, Margarino G, Danova M, Vitale V.
    Radiol Med; 1991 Aug 25; 82(1-2):147-52. PubMed ID: 1896568
    [Abstract] [Full Text] [Related]

  • 4. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
    Margarino G, Scala M, Schenone G, Mereu P, Corvo R, Sanguineti G, Giaretti W, Geido E, Orecchia R, Meszaros P.
    Acta Otorhinolaryngol Ital; 1992 Aug 25; 12(5):421-33. PubMed ID: 1303006
    [Abstract] [Full Text] [Related]

  • 5. Chemoradiotherapy as an alternative to radiotherapy alone in fast proliferating head and neck squamous cell carcinomas.
    Corvó R, Giaretti W, Sanguineti G, Geido E, Bacigalupo A, Orecchia R, Benasso M, Numico GM, Merlano M, Margarino G, Vitale V.
    Clin Cancer Res; 1997 Nov 25; 3(11):1993-7. PubMed ID: 9815589
    [Abstract] [Full Text] [Related]

  • 6. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
    Corvò R, Giaretti W, Sanguineti G, Geido E, Orecchia R, Barra S, Margarino G, Bacigalupo A, Vitale V.
    Int J Radiat Oncol Biol Phys; 1993 Dec 01; 27(5):1165-72. PubMed ID: 8262843
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
    Edström S, Cvetkovska E, Westin T, Young C.
    Laryngoscope; 2001 Jan 01; 111(1):124-30. PubMed ID: 11192880
    [Abstract] [Full Text] [Related]

  • 8. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
    Bourhis J, Dendale R, Hill C, Bosq J, Janot F, Attal P, Fortin A, Marandas P, Schwaab G, Wibault P, Malaise EP, Bobin S, Luboinski B, Eschwege F, Wilson G.
    Int J Radiat Oncol Biol Phys; 1996 Jun 01; 35(3):471-6. PubMed ID: 8655369
    [Abstract] [Full Text] [Related]

  • 9. In vivo cell kinetics in elderly patients affected by squamous cell carcinoma of the head and neck.
    Corvò R, Sanguineti G, Vitale V, Bacigalupo A, Margarino G, Benasso M, Numico GM, Giaretti W.
    Rays; 1997 Jun 01; 22(1 Suppl):69-72. PubMed ID: 9250019
    [Abstract] [Full Text] [Related]

  • 10. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen.
    Corvò R, Giaretti W, Sanguineti G, Geido E, Orecchia R, Guenzi M, Margarino G, Bacigalupo A, Garaventa G, Barbieri M.
    J Clin Oncol; 1995 Aug 01; 13(8):1843-50. PubMed ID: 7636527
    [Abstract] [Full Text] [Related]

  • 11. Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.
    Alsner J, Høyer M, Sørensen SB, Overgaard J.
    Int J Radiat Oncol Biol Phys; 2001 Feb 01; 49(2):519-25. PubMed ID: 11173149
    [Abstract] [Full Text] [Related]

  • 12. Interstitial high dose rate brachytherapy in locally progressive or recurrent head and neck cancer.
    Krüll A, Friedrich RE, Schwarz R, Thurmann H, Schmelzle R, Alberti W.
    Anticancer Res; 1999 Feb 01; 19(4A):2695-7. PubMed ID: 10470222
    [Abstract] [Full Text] [Related]

  • 13. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements.
    Perez LA, Dombkowski D, Efird J, Preffer F, Suit HD.
    Cancer Res; 1995 Jan 15; 55(2):392-8. PubMed ID: 7812972
    [Abstract] [Full Text] [Related]

  • 14. Is there a future for cell kinetic measurements using IdUrd or BdUrd?
    Haustermans K, Fowler JF.
    Int J Radiat Oncol Biol Phys; 2001 Feb 01; 49(2):505-11. PubMed ID: 11173147
    [Abstract] [Full Text] [Related]

  • 15. The use of bromodeoxyuridine cytokinetic studies as a prognostic indicator of cancer of the head and neck.
    Hirano T, Zitsch RP, Gluckman JL.
    Laryngoscope; 1991 Feb 01; 101(2):130-3. PubMed ID: 1704093
    [Abstract] [Full Text] [Related]

  • 16. Cell kinetics of head and neck cancers.
    Kotelnikov VM, Coon JS IV, Haleem A, Taylor S IV, Hutchinson J, Panje W, Caldarelli DD, Griem K, Preisler HD.
    Clin Cancer Res; 1995 May 01; 1(5):527-37. PubMed ID: 9816012
    [Abstract] [Full Text] [Related]

  • 17. Predicting response to therapy of squamous cell carcinoma of the head and neck (review).
    Wennerberg J.
    Anticancer Res; 1996 May 01; 16(4C):2389-96. PubMed ID: 8816840
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 19. In vivo cell kinetic measurements in a randomized trial of continuous hyperfractionated accelerated radiotherapy with or without mitomycin C in head-and-neck cancer.
    Dobrowsky W, Dobrowsky E, Wilson GD.
    Int J Radiat Oncol Biol Phys; 2003 Mar 01; 55(3):576-82. PubMed ID: 12573744
    [Abstract] [Full Text] [Related]

  • 20. Cell kinetics and tumor regression during radiotherapy in head and neck squamous-cell carcinomas.
    Corvò R, Giaretti W, Geido E, Sanguineti G, Orecchia R, Scala M, Garaventa G, Mora E, Vitale V.
    Int J Cancer; 1996 Oct 09; 68(2):151-5. PubMed ID: 8900419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.